Publisher
Springer Science and Business Media LLC
Reference50 articles.
1. Cook JL, Colvin M, Francis GS, Grady KL, Hoffman TM, Jessup M, et al. Recommendations for the use of mechanical circulatory support: ambulatory and community patient care: a scientific statement from the American Heart Association. Circulation. 2017;135(25):e1145–e58. https://doi.org/10.1161/CIR.0000000000000507.
2. Kormos RL, Cowger J, Pagani FD, Teuteberg JJ, Goldstein DJ, Jacobs JP, et al. The Society of Thoracic Surgeons Intermacs database annual report: evolving indications, outcomes, and scientific partnerships. Ann Thorac Surg. 2019;107(2):341–53. https://doi.org/10.1016/j.athoracsur.2018.11.011.
3. Muggia VA, Minamoto GY, Forest SJ, Lerman DT, Puius YA. Chapter 3. Left ventricular assist device infections: a practical approach. In: Murielle R, editor. Ventricular Assist Devices: Management, Outcomes and Complications. Hauppauge: Nova Science Publishers., Inc.; 2018. p. 127–64. https://novapublishers.com/wp-content/uploads/2019/01/978-1-53613-891-7_ch3.pdf.
4. • Seguchi O, Fujita T, Murata Y, Yanase M, Higashi M, Toda K, et al. Bone-destroying candida infection following left ventricular assist device explant. J Artif Organs. 2013;16(2):258–62. https://doi.org/10.1007/s10047-013-0696-2. A noteworthy case ofCandida albicanssoft tissue infection and osteomyelitis complicating an LVAD.
5. •• Koval CE, Stosor V, Practice AICo. Ventricular assist device-related infections and solid organ transplantation-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transpl. 2019:e13552. https://doi.org/10.1111/ctr.13552. The most recent guidelines regarding diagnosis and management of left ventricular assist device infections, with discussion of epidemiology.